Trisubstituted amine compound
AssigneeMitsubishi Tanabe Pharma Corporation
InventorsYoshinori Nakamura, Norimitsu Hayashi, Takanori Higashijima, Hitoshi Kubota, Kozo Oka
Life of this patent
Estimating the term…
Loading patent…
AssigneeMitsubishi Tanabe Pharma Corporation
InventorsYoshinori Nakamura, Norimitsu Hayashi, Takanori Higashijima, Hitoshi Kubota, Kozo Oka
Estimating the term…
The present invention relates to a compound of the general formula (1): wherein, Y is a methylene group, and the like; A is an optionally substituted heterocyclic group, and the like; B is an optionally substituted heterocyclic group, and the like; R1 is an optionally substituted alkyl group, wherein the alkyl group further may optionally be substituted by an optionally substituted homocyclic group, and the like; and R2 is an optionally substituted amino group, and the like; or a pharmaceutically acceptable derivative thereof, which has an inhibitory activity against cholesteryl ester transfer protein (CETP), thereby being useful for prophylaxis and/or treatment of arteriosclerotic diseases, hyperlipemia or dyslipidemia, and the like.
A compound of the general formula (1):
A compound described in any one of examples No. 1, 4, 5, 14, 21 and 23, or a pharmaceutically acceptable derivative thereof.
A compound of the formula (I-A):
A compound of the formula (I-B):
A compound described in any one of examples No. 52, 54, 55, 57, 58, 60, 63, 65, or a pharmaceutically acceptable derivative thereof.
A compound described in any one of examples No. 77 to 84, or a pharmaceutically acceptable derivative thereof.
Dependencies are inferred from the claim text.